Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Merkel Cell

Explore clinical trials studying Carcinoma, Merkel Cell. Study availability and eligibility vary by location and protocol.

103 public trials 29 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Merkel Cell trial results

Completed

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

NCT03000257

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +56 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 157374 La Jolla, California, United States
  • The University of Chicago Medical Center /ID# 157375 Chicago, Illinois, United States
  • Carolina BioOncology Institute /ID# 157376 Huntersville, North Carolina, United States
  • South Texas Accelerated Research Therapeutics /ID# 157378 San Antonio, Texas, United States
View all 26 locations
View Trial Details
Completed

A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma

NCT01652547

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
Locations
  • Novartis Investigative Site Essen, Germany
  • Novartis Investigative Site Lausanne, Switzerland
  • Novartis Investigative Site Zurich, Switzerland
View Trial Details
Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

NCT03538028

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
Locations
  • The Angeles Clinic and Research Center Los Angeles, California, United States
  • Hackensack Medical Center Hackensack, New Jersey, United States
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details

Related conditions